Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Significant gaps in access to care have shifted the burden of cervical cancer disease to resource-poor countries in Africa, Asia and Latin America. The recent World Health Organization’s Call to Action to eliminate cervical cancer is a unique opportunity to galvanize change and remove barriers to prevention and care.
A systematic approach to understanding the noncoding genome in cancer promises to improve cancer diagnosis and therapy. New technologies and bold therapeutic approaches are paving the way to truly envisage personalized cancer medicine in the future.
Cancer genomics research in Africa is crucial to understanding the genetic architecture of cancer and tailoring cancer diagnoses and therapies to African populations. Creating this research enterprise in Africa has to be purposeful with a roadmap that incorporates individual scientist-, international collaborator-, university or institution-, and scientific organization-level factors.
The incidence of early-onset colorectal cancer (EOCRC) continues to rise and disproportionately affects people of African descent. This Comment advocates for mechanistic studies that can help mitigate EOCRC disparities.
Research funders are uniquely placed to develop and promote collaborations between multiple partners, including industry, in a positive and ethical way. This Comment calls for funders to take action to ensure that discoveries progress from the lab to patients with cancer.
